47 results on '"Letendre, Scott L."'
Search Results
2. Genetic Variations in EIF2AK3 are Associated with Neurocognitive Impairment in People Living with HIV
Catalog
Books, media, physical & digital resources
3. Combined effects of loneliness and inflammation on depression in people with HIV
4. Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression
5. Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program
6. Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model
7. Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment
8. Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid
9. A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men
10. Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era
11. Race-Dependent Association of Single-Nucleotide Polymorphisms in TrkB Receptor in People Living with HIV and Depression
12. Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV
13. Gut microbiota dysbiosis is associated with worse emotional states in HIV infection
14. A comprehensive data-driven analysis framework for detecting impairments in brain function networks with resting state fMRI in HIV-infected individuals on cART
15. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV
16. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior
17. Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis
18. Correction to: A Cross‑Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men
19. Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy
20. Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS
21. Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study
22. Update and New Directions in Therapeutics for Neurological Complications of HIV Infections
23. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study
24. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection
25. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
26. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease
27. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease
28. Individualized Texting for Adherence Building (iTAB): Improving Antiretroviral Dose Timing Among HIV-Infected Persons with Co-occurring Bipolar Disorder
29. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment
30. A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older
31. Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?
32. Real-world impact of neurocognitive deficits in acute and early HIV infection
33. A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals
34. Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits
35. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection
36. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection
37. HIV-Infected Individuals with Co-occurring Bipolar Disorder Evidence Poor Antiretroviral and Psychiatric Medication Adherence
38. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat
39. Clinical factors related to brain structure in HIV: the CHARTER study
40. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals
41. Neurocognitive functioning in acute or early HIV infection
42. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
43. Successful cognitive aging in persons living with HIV infection
44. Neurocognitive Effects of the Hepatitis C Virus
45. White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals
46. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy
47. The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.